Overview
- The Albemarle County site at Rivanna Futures will be AstraZeneca’s largest manufacturing facility, located about 120 miles southwest of Washington.
- The project adds antibody-drug conjugate cancer manufacturing to planned production of drug substance for weight-management and metabolic medicines, including an oral GLP-1, baxdrostat and an oral PCSK9.
- AstraZeneca expects roughly 3,600 direct and indirect jobs, including about 600 highly skilled permanent roles and around 3,000 construction jobs.
- Work begins immediately with operations targeted to start in four to five years, according to the company.
- The investment, increased by $500 million from initial plans, fits into AstraZeneca’s $50 billion U.S. expansion as federal and state leaders urge onshoring, with CMS Administrator Dr. Mehmet Oz praising the move at the groundbreaking.